BioCorRx (BICX) Retained Earnings (2010 - 2026)

BioCorRx has disclosed Retained Earnings across 17 years of filings, most recently posting -$87.5 million for Q1 2026.

• Retained Earnings for Q1 2026 came in at -$87.5 million, down 4.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$87.5 million (down 4.08% YoY), and the FY2025 annual result was -$86.6 million, down 4.13% from the prior year.
• Retained Earnings came in at -$87.5 million for Q1 2026 at BioCorRx, down from -$86.6 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $1.1 million in Q3 2025 to a low of -$87.5 million in Q1 2026.
• The 5-year median for Retained Earnings is -$78.1 million (2023), against an average of -$74.4 million.
• Across the five-year window, Retained Earnings fell 7.27% in 2022 and jumped 101.31% in 2025, its largest moves.
• BioCorRx's Retained Earnings stood at -$74.3 million in 2022, then declined by 5.07% to -$78.1 million in 2023, then declined by 6.54% to -$83.2 million in 2024, then slipped by 4.13% to -$86.6 million in 2025, then slipped by 0.96% to -$87.5 million in 2026.
• The last three Retained Earnings figures came in at -$87.5 million (Q1 2026), -$86.6 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.